These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12054172)

  • 21. Treatment of rheumatoid arthritis--we're getting closer.
    Kushner I; Ballou SP
    J Rheumatol; 1999 Nov; 26(11):2291-3. PubMed ID: 10555878
    [No Abstract]   [Full Text] [Related]  

  • 22. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 23. [COX-2 inhibitors: current status and outlook].
    Dannhardt G; Hahn L
    Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
    [No Abstract]   [Full Text] [Related]  

  • 24. New perspectives for nonsteroidal antiinflammatory therapy.
    de Brum-Fernandes AJ
    J Rheumatol; 1997 Feb; 24(2):246-8. PubMed ID: 9034978
    [No Abstract]   [Full Text] [Related]  

  • 25. Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice.
    Wormser U; Langenbach R; Peddada S; Sintov A; Brodsky B; Nyska A
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):40-7. PubMed ID: 15451306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats.
    Fong LY; Zhang L; Jiang Y; Farber JL
    J Natl Cancer Inst; 2005 Jan; 97(1):40-50. PubMed ID: 15632379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [COX-1 and COX-2: functions and pharmacological effects].
    Hinz B; Brune K
    Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
    [No Abstract]   [Full Text] [Related]  

  • 28. [What's in the future? New NSAIDs].
    Laufer S
    Pharm Unserer Zeit; 2002; 31(2):164-9. PubMed ID: 11977452
    [No Abstract]   [Full Text] [Related]  

  • 29. [Biological functions of cyclooxygenase 2: control of its expression and activity].
    Jacquemin C
    J Soc Biol; 2000; 194(3-4):189-93. PubMed ID: 11324321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled indomethacin in bronchorrhea in bronchioloalveolar carcinoma: role of cyclooxygenase.
    Tamaoki J; Kohri K; Isono K; Nagai A
    Chest; 2000 Apr; 117(4):1213-4. PubMed ID: 10767270
    [No Abstract]   [Full Text] [Related]  

  • 31. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-2 inhibitors.
    Nies AS; Gresser MJ
    Adv Protein Chem; 2001; 56():115-41. PubMed ID: 11329851
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible inconsistencies in study on cyclooxygenase.
    Kay-Mugford T; Conlon P
    Am J Vet Res; 1999 Mar; 60(3):275-6. PubMed ID: 10188806
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of novel anti-inflammatory compounds on healing of acetic acid-induced gastric ulcer in rats.
    Lesch CA; Gilbertsen RB; Song Y; Dyer RD; Schrier D; Kraus ER; Sanchez B; Guglietta A
    J Pharmacol Exp Ther; 1998 Oct; 287(1):301-6. PubMed ID: 9765350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do COX-2 inhibitors reduce renal fibrosis?
    Harding P
    J Hypertens; 2004 Jan; 22(1):43-5. PubMed ID: 15106792
    [No Abstract]   [Full Text] [Related]  

  • 36. [Topical pharmacology. COX-2 inhibitors].
    Heinzl S
    Med Monatsschr Pharm; 1999 Oct; 22(10):298-304. PubMed ID: 10540801
    [No Abstract]   [Full Text] [Related]  

  • 37. The classification of cyclooxygenase inhibitors.
    Lipsky LP; Abramson SB; Crofford L; Dubois RN; Simon LS; van de Putte LB
    J Rheumatol; 1998 Dec; 25(12):2298-303. PubMed ID: 9858421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, against PhIP-induced mammary carcinogenesis.
    Kawamori T; Nakatsugi S; Ohta T; Sugimura T; Wakabayashi K
    Adv Exp Med Biol; 2002; 507():371-6. PubMed ID: 12664612
    [No Abstract]   [Full Text] [Related]  

  • 39. Mechanism of cyclooxygenase-2 inhibition by indanone derivatives.
    Klein T; NĂ¼sing RM
    Adv Exp Med Biol; 1997; 407():503-7. PubMed ID: 9321998
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
    Milas L; Kishi K; Hunter N; Mason K; Masferrer JL; Tofilon PJ
    J Natl Cancer Inst; 1999 Sep; 91(17):1501-4. PubMed ID: 10469752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.